> top > docs > PMC:7253482 > spans > 232-405 > annotations
TextAE configuration unavailable!

PMC:7253482 / 232-405 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
27 159-170 Species denotes Coronavirus Tax:11118
33 135-140 Gene denotes spike Gene:43740568

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 145-157 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 54-61 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 145-157 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T2 106-129 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 114-129 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T34 4-9 NNS denotes rates
T35 10-13 CC denotes and
T36 14-22 JJ denotes pandemic
T37 23-32 NN denotes potential
T38 34-41 NN denotes Vaccine
T39 42-53 NN denotes development
T40 54-61 VBZ denotes focuses
T41 62-64 IN denotes on
T42 65-68 DT denotes the
T43 69-78 JJ denotes principal
T44 79-85 NN denotes target
T45 86-88 IN denotes of
T46 89-92 DT denotes the
T47 93-105 VBG denotes neutralizing
T48 106-113 JJ denotes humoral
T49 114-120 JJ denotes immune
T50 121-129 NN denotes response
T51 129-130 -COMMA- denotes ,
T52 131-134 DT denotes the
T53 135-140 NN denotes spike
T54 141-142 -LRB- denotes (
T55 142-143 NN denotes S
T56 143-144 -RRB- denotes )
T57 145-157 NN denotes glycoprotein
T58 159-170 NN denotes Coronavirus
T59 171-172 NN denotes S
R32 T34 T35 arg1Of rates,and
R33 T37 T35 arg2Of potential,and
R34 T37 T36 arg1Of potential,pandemic
R35 T39 T38 arg1Of development,Vaccine
R36 T39 T40 arg1Of development,focuses
R37 T40 T41 arg1Of focuses,on
R38 T44 T41 arg2Of target,on
R39 T44 T42 arg1Of target,the
R40 T44 T43 arg1Of target,principal
R41 T44 T45 arg1Of target,of
R42 T50 T45 arg2Of response,of
R43 T50 T46 arg1Of response,the
R44 T50 T47 arg1Of response,neutralizing
R45 T50 T48 arg1Of response,humoral
R46 T50 T49 arg1Of response,immune
R47 T50 T51 arg1Of response,","
R48 T57 T51 arg2Of glycoprotein,","
R49 T57 T52 arg1Of glycoprotein,the
R50 T57 T53 arg1Of glycoprotein,spike
R51 T53 T54 arg1Of spike,(
R52 T55 T54 arg2Of S,(
R53 T56 T54 arg3Of ),(

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 145-157 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 145-157 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T4 34-158 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
33 135-140 Gene denotes spike Gene:43740568
27 159-170 Species denotes Coronavirus Tax:11118

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 141-157 Protein denotes (S) glycoprotein https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P30019|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94|https://www.uniprot.org/uniprot/Q4ZJS1

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T2 106-129 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 114-129 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T2 106-129 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 114-129 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T2 106-129 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 114-129 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 34-158 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.